Condition
Biomarker in Early Diagnosis
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Recruiting2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07293481Recruiting
Discovery and Validation of Periodontitis Biomarkers
NCT07401849Not Yet Recruiting
Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
NCT07353502Not ApplicableRecruiting
miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction
NCT06719453Completed
Prevalence of Alzheimer's Disease Pathology in the Community
NCT06701058Completed
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
NCT05733195Unknown
The Study of Biomarker in Early Diagnosis of GDM by Metabolomics
Showing all 6 trials